Viewing StudyNCT02386436



Ignite Creation Date: 2024-05-06 @ 3:50 AM
Last Modification Date: 2024-10-26 @ 11:39 AM
Study NCT ID: NCT02386436
Status: COMPLETED
Last Update Posted: 2017-05-15
First Post: 2015-03-06

Brief Title: A Safety Tolerability Pharmacokinetics and Pharmacodynamics Study of GSK2330811 in Healthy Subjects
Sponsor: GlaxoSmithKline
Organization: GlaxoSmithKline

Conditions & Keywords Data

Conditions:
Name
Scleroderma Systemic
Keywords:
Name View
Pharmacokinetics View
GSK2330811 View
Dose Escalation View
Safety View
First Time in Human View
Pharmacodynamics View